# Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients

> **NCT04420988** · — · NO_LONGER_AVAILABLE · sponsor: **Rutgers, The State University of New Jersey**

## Conditions studied

- COVID-19
- SARS-CoV 2
- SARS-CoV Infection

## Interventions

- **BIOLOGICAL:** COVID-19 Convalescent Plasma

## Key facts

- **NCT ID:** NCT04420988
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04420988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04420988, "Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04420988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*